0001203311-23-000116.txt : 20230922
0001203311-23-000116.hdr.sgml : 20230922
20230922194600
ACCESSION NUMBER: 0001203311-23-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230921
FILED AS OF DATE: 20230922
DATE AS OF CHANGE: 20230922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROMP CHARLES R
CENTRAL INDEX KEY: 0001809717
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 231272802
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-09-21
0
0001060736
Seagen Inc.
SGEN
0001809717
ROMP CHARLES R
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
EVP, Commercial U.S.
0
Common Stock
2023-09-21
4
S
0
45
206.5
D
69111
D
The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/2/2021 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jennifer Prosba For: Charles R Romp
2023-09-22